Země: Itálie
Jazyk: angličtina
Zdroj: HMA (Heads of Medicines Agencies)
fusidic acid 10 mg/g
Dechra Veterinary Products A/S Denmark
QS01AA13
Eye drops, suspension
fusidic acid
Dogs
2012-01-03
1 _[Version 7.2, 12/2008] _ _Type IB Harmonisation of package information leaflet _ _09/2010(TC)10/2012 _ PACKAGE LEAFLET 2 PACKAGE LEAFLET FUCITHALMIC VET 10 MG/G EYE DROPS, SUSPENSION FOR DOG (DK, AT, PT) CONOPTAL, 1 % EYE DROPS, SUSPENSION FOR DOGS (IT) 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT] MARKETING AUTHORISATION HOLDER: Dechra Veterinary Products A/S Mekuvej 9 DK-7171 Uldum Denmark MANUFACTURER FOR THE BATCH RELEASE: LEO Laboratories Ltd. 285 Cashel Road Dublin 12 Ireland 2. NAME OF THE VETERINARY MEDICINAL PRODUCT Fucithalmic vet. 10 mg/g eye drops, suspension for dogs (DK, AT, PT) Conoptal 1 % eye drops, suspension for dogs (IT) Fusidic acid 3. STATEMENT OF THE ACTIVE SUBSTANCE AND OTHER INGREDIENTS 1 g eye drops, suspension contains: Active substance: Fusidic acid 10 mg Adjuvants: Benzalkonium chloride 0.11 mg Disodium edetate 0.5 mg Excipients : Carbomer, mannitol, sodium hydroxid, water for injection Sterile, white to off-white viscous eye drops suspension. 4. INDICATION Eye infections in dogs caused by fusidic acid - sensitive bacteria. 5. CONTRAINDICATIONS Fucithalmic vet./ Conoptal should not be used in conjunctivitis cases associated with _Pseudomonas _ _spp. _ Do not use in case of known hypersensitivity to the active substance, any of the adjuvants or excipients. 3 6. ADVERSE REACTIONS Allergic reactions or hypersensitivity reactions to the active substance or the excipient might occur. If you notice any serious effects or ot Přečtěte si celý dokument